1. Ventilation was measured during normoxia, hypoxia and hypercapnia before and after administration of almitrine in conscious, unrestrained, tracheostomized rats with the superior laryngeal nerves intact or cut. In superior laryngeal nerve-intact animals breathing air, almitrine increased minute ventilation due to an increase in respiratory frequency with no change in tidal volume. In superior laryngeal nerve-sectioned animals, the minute ventilatory response to almitrine was reduced due to a reduced tidal volume component of the response. Almitrine increased the ventilatory response to hypercapnia in superior laryngeal nerve-intact but not in sectioned animals.
INTRODUCTION
Almitrine bismesylate is used in the treatment of chronic obstructive pulmonary disease [l] and hypoventilation syndromes [2] . The stimulant action of almitrine on respiration is well established for rats [3] , rabbits [4] , cats [S] , dogs [6] and man [7] , but its effects on the ventilatory responses to hypoxia and hypercapnia are controversial. In man, the ventilatory effects of almitrine were reported to be abolished after bilateral surgical excision of the carotid body as a treatment for breathlessness [S]. This is consistent with the drug's action as a peripheral arterial chemoreceptor stimulant. However, in cats and dogs, some ventilatory effect remains after carotid sinus nerve section [9] , suggesting that almitrine may also act on glomus tissue other than the carotid bodies. The superior laryngeal nerves (SLNs) have been shown to contain paraganglia that morphologically and biochemically resemble the carotid body [lo] . Although the functions of the laryngeal paraganglia are unknown, it is speculated that they possess chemoreceptor properties [ll] .
In order to test the hypothesis that almitrine may exert part of its ventilatory effect through a direct action on the SLNs and to study almitrine's interaction with hypoxia and hypercapnia, we have examined the ventilatory effects of almitrine before and after SLN section in conscious, tracheostomized rats breathing air and hypoxic and hypercapnic gas mixtures. The rationale for the tracheostomy was that the upper airway was now bypassed and thus effects on SLN afferent activity secondary to the almitrine-induced increase in ventilation would be minimized. An almitrine-induced hyperpnoea would in itself alter the activity of upper airway receptors in the SLNs so that changes in the ventilatory response to almitrine as a result of SLN section could not be ascribed to a direct effect of almitrine on SLN paraganglia unless the upper airway was bypassed with a tracheostomy.
It has been suggested that almitrine may also have a useful role to play in the treatment of diseases involving pharyngeal airway obstruction [12] . Pharyngeal airway obstruction occurs when the dilating and stabilizing force of the upper airway muscles is insufficient to counterbalance the negative pharyngeal pressure produced by the inspiratory pump muscles during inspiration 1131. There is evidence that peripheral arterial chemoreceptor stimulation preferentially increases upper airway compared with diaphragm muscle activity [14] and we hypothesize that almitrine should do likewise. Little attention, however, has been focused on the effects of almitrine on upper airway dilator muscles, although one report has shown that almitrine causes a reduction in the duration of apnoeic events in adults with obstructive sleep apnoea [l5]. The present study, therefore, also examines the effects of almitrine on geniohyoid and diaphragm electromyographic (EMG) activity in anaesthetized rats. We chose to study the geniohyoid muscle because it is readily accessible in the rat and because of its importance as an upper airway dilator. Contraction of the geniohyoid causes anterior displacement of the hyoid bone and dilation and stiffening of the hypopharynx [13] . Although the site of upper airway collapse is confined to the oropharynx in approximately 50% of patients with obstructive sleep apnoea, the region of collapse also includes the hypopharynx in the remaining 50% [16] .
METHODS

Recording of ventilation in conscious animals
In order to examine the effects of almitrine on ventilation and on the ventilatory response to hypoxia and hypercapnia before and after SLN section, 27 male Wistar rats (body weight 400-500 g) were anaesthetized with diethyl ether and a thinwalled cannula was inserted into a low-cervical tracheostomy. Animals were randomly divided into two groups, one of 18 animals in which the SLNs were exposed bilaterally and cleared from surrounding connective tissue, towards the larynx and the vagus trunk, but left intact, and another group of nine animals in which the SLNs were bilaterally sectioned, close to their merging in the vagus trunk, and a piece of nerve was removed. In this way, putative afferent activity from paraganglia in the SLNs was eliminated. The incision was closed and the animals were allowed to recover completely. Ventilation and ventilatory responses to hypoxia and hypercapnia were measured before and 30 min after the administration of an intraperitoneal injection of almitrine bismesylate (Servier Laboratories Ltd) at a dose of 5mg/kg or an equal volume of the drug's vehicle (0.6% malic acid). Almitrine was given to nine SLN-intact and nine SLN-sectioned animals and vehicle was given to a separate group of nine SLN-intact animals.
Conscious, unrestrained animals were placed in a 21 sealed, air-tight, perspex chamber and allowed an exploratory period of at least 30min to accustom themselves to the chamber before any ventilatory measurements were carried out. The animal chamber was continuously flushed with warmed (24"C), saturated (100% relative humidity) air containing 0, 3, 6 and 9% C0,and 10% 0, in N, at a rate of 6l/min. CO, and 10% 0, gas mixtures were generated by mixing air with 100% CO, and with 100% N, respectively.
Five minutes were allowed for equilibration with each gas mixture. At the end of this period, the inlet and outlet tubes of the animal chamber were clamped and pressure fluctuations within the chamber (due to the animals breathing) were measured relative to an identical reference chamber using a differential pressure transducer (Type M3; Mercury Electronics Ltd, Glasgow, U.K.) connected in series between the two chambers. The signal was digitized and recorded using a data acquisition system (MacLab Mk3; AD Instruments, NSW, Australia) and stored for later analysis on a microcomputer (Apple Macintosh LC 111; Apple Computer Inc., CA, U.S.A.). The O2 and CO, concentrations of the gases flushing the plethysmograph were analysed using fuel cell 0, and IR CO, analysers respectively (Eliza Duo; Gambro Engstrom AB, Bromma, Sweden). Calibrations were performed by repeatedly injecting 0.1-0.2ml of air into the chamber using a spring-loaded Hamilton syringe (Becton Dickinson and Co., U.S.A.) and measuring the consequent pressure deflection of the wave-form pattern. The entire system was immersed in a water bath (Model 20E Gallenkamp and Co. Ltd., London, U.K.) and a constant comfortable temperature of 24°C was maintained within the animal chamber.
Data analysis
Respiratory frequency and inspiratory and expiratory duration were obtained from direct measurement of the recordings obtained. Tidal volume was calculated according to the equations derived by Drorbaugh and Fenn [17] . Minute ventilation was calculated as the product of respiratory frequency and the calculated tidal volume. Values were obtained from 10 to 20 consecutive breaths during a steady-state period for each trial where breathing was regular and movement artefact was absent. Ten to twenty breaths were chosen for analysis because a longer period of recording (and therefore more breaths) would have increased the possibility of rebreathing in the closed system of the plethysmograph. All challenges were preceded and followed by air trials. All data are expressed as mean absolute values or as mean percentage change from control k SD. Values for tidal volume, minute ventilation and mean inspiratory flow are expressed per lOOg of body weight. Statistical analysis was performed using one-way, two-way and three-way analysis of variance where appropriate using almitrine or vehicle, SLN section and gas mixture as independent variables followed by Fisher's least significance test. Differences were considered significant at P < 0.05.
EMG recording
Experiments were performed on 11 male Wistar rats (body weight 500-600 g) anaesthetized with 100 mg/kg cr-chloralose and 1 g/kg urethane injected intraperitoneally. Animals were placed supine and rectal temperature was monitored continuously and maintained at 37°C with a heating pad and radiant heat. A jugular vein was cannulated to administer almitrine (0.5 mg/kg) or supplemental anaesthetic as required. A common carotid artery was cannulated to record arterial blood pressure. Since head and jaw position affect upper airway muscle activity [18] , the head was placed with the mouth closed so that there was no lateral flexion or rotation of the neck and the amount of neck extension was the natural position assumed which did not vary during the course of the experiments. Animals breathed room air spontaneously through a cannula inserted into a low-cervical tracheostomy with the aid of a binocular microscope. The vagus nerves were identified and sectioned bilaterally. The digastric muscles were identified and carefully separated to reveal the underlying omohyoid muscle which was cut in order to expose the geniohyoid muscles. The geniohyoid muscles consist of two parallel strips of muscle running from the midpoint of the mandible to the hyoid bone and bonded medially by dense connective tissue. Care was taken to preserve the vascular and neural integrity of the muscles. Bipolar, fine copper wire electrodes (outside diameter 0.02 mm, insulated except for 1-2mm at the tips) were placed in the central portion of the muscle on one side and spaced approximately 5 mm apart. Each wire was passed through a hypodermic needle (23-gauge) which was used to insert the wire into the muscle, and the wire was bent at its tip into a hook to allow it to remain embedded in the muscle after the needle was withdrawn. Similar electrodes were inserted under direct vision into the costal diaphragm through an abdominal incision which was then closed. Electrode locations were verified at the end of each experiment. EMG signals were bandpass filtered between 10 and 6000Hz, rectified and amplified (Neurolog NL 104; Digitimer Ltd, Hertfordshire, U.K.) and the resulting signal was integrated (Neurolog NL 703; Digitimer Ltd). Raw and integrated EMG activity together with arterial blood pressure signals were digitized and recorded on a microcomputer as described above. The effects of a single intravenous injection of almitrine on EMG activity were examined. In all animals, the effects of vehicle were also examined.
Data analysis
Phasic inspiratory diaphragm and geniohyoid integrated EMG activity was quantified as the height of the peak integrated signal from endexpiratory level in arbitrary units. Mean peak integrated EMG activity, respiratory frequency and inspiratory and expiratory duration were calculated for the last 20-30 consecutive breaths during the control period, and for 20-30 consecutive breaths 30 min after almitrine administration when effects were maximal. In order to enhance statistical reliability, it was possible to analyse more breaths compared with the plethysmography measurements since we were not constrained by rebreathing or movement artefact. All values are expressed as mean percentage change from control f SD. Responses to almitrine were compared with pre-trial control values using Student's t-test with P<0.05 considered significant.
RESULTS
Effect of almitrine on geniohyoid and diaphragm activity in anaesthetized animals
In all animals, the geniohyoid muscle had phasic inspiratory activity which slightly preceded that of the diaphragm. Vagotomy caused typical decreases in respiratory frequency and increases in diaphragm and geniohyoid EMG activity. An intravenous injection of almitrine had no significant effect on respiratory frequency or inspiratory and expiratory duration ( Fig. la) but caused significant increases in peak integrated diaphragm and geniohyoid EMG activity (Fig. lb) . The increase in peak integrated geniohyoid EMG activity (132.0&21.3%) was much greater than that for diaphragm activity (29.3 13.6%). The amount of preactivation of the geniohyoid compared with the diaphragm was unaffected by almitrine. Thus, the time between activation of the geniohyoid and the diaphragm was 76&81ms and 80)75ms before and during almitrine respectively. Vehicle administration had no significant effect on any measured variable. Figure 2 shows an example of the effect of almitrine on diaphragm and geniohyoid EMG activity.
Ventilatory responses to almitrine in conscious animals with SLNs intact
Data for ventilatory variables in normoxia, hypoxia and hypercapnia before and after an intraperitoneal injection of almitrine in nine tracheostomized animals with intact SLNs are given in Table  1 . It shows that while breathing air, almitrine caused significant increases in respiratory frequency, minute ventilation and mean inspiratory flow and significant decreases in inspiratory and expiratory duration, but had no significant effect on respiratory duty cycle or tidal volume. The ventilatory response to 10% O2 and to 3, 6 and 9% C 0 2 before and after injection of almitrine is shown in Fig. 3 . When expressed as a percentage change from air, there was no significant difference in the ventilatory response to hypoxia for any of the ventilatory variables measured, before or after almitrine treatment. Ventilatory responses to 6 and 9% C 0 2 were increased by almitrine treatment, although statistical significance was achieved for 6% C 0 2 only. The ventilatory responses for both tidal volume and minute ventilation were significantly higher for 6% CO, after almitrine. After an equal-volume intraperitoneal injection of the drug's vehicle in nine addi-2o 1 ponse to hypoxia or hypercapnia for any of the ventilatory variables.
Role of the SLNs in the ventilatory response to almitrine
In SLN-intact animals breathing air, almitrine significantly increased minute ventilation and mean inspiratory flow due to an increase in respiratory frequency, with no change in tidal volume. In SLNdenervated animals breathing air, the ventilatory response to almitrine was significantly reduced owing to a reduction in the tidal component of the ventilatory response with no change in the frequency component of the response. In addition, mean inspiratory flow was unaffected in SLNdenervated animals. Thus, in SLN-denervated animals breathing air, there was a small but significant reduction in the ventilatory response to almitrine. In addition, the ventilatory response to hypercapnia after almitrine administration was significantly different in both groups (Fig. 4) . In SLN-intact animals, the ventilatory response to C 0 2 was increased compared with control, a response significantly different to that in SLN-denervated animals in which hypercapnic sensitivity was unaltered after almitrine administration. Almitrine had no effect on the ventilatory response to hypoxia either in SLNintact or SLN-sectioned animals (Fig. 4) . tional animals, there were no significant differences in any of the ventilatory variables measured. Similarly, hypoxic and hypercapnic responses were unaffected after vehicle administration. Table 2 gives data for ventilatory variables in normoxia, hypoxia and hypercapnia before and after almitrine administration in nine animals with the SLNs sectioned. It shows that while breathing air, almitrine caused significant increases in respiratory frequency and minute ventilation and significant decreases in inspiratory and expiratory duration, but had no significant effect on tidal volume, mean inspiratory flow or respiratory duty cycle. The ventilatory response to 10% O2 and to 3, 6 and 9% C 0 2 before and after injection of almitrine is shown in Fig. 4 . When expressed as a percentage change from air, almitrine had no effect on the ventilatory res-
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DISCUSSION
In the present study, the changes in ventilation caused by almitrine in tracheostomized, conscious rats compare well with those reported in the literature. Dhillon . Such effects are probably due to differences in dead space, airway resistance and loss of upper airway sensory function compared with airway-intact animals. Certainly, loss of sensory function is a factor since the present experiments show that SLN section in tracheostomized animals does not affect ventilatory variables while breathing air, whereas our previous work has shown that SLN section does alter ventilation in airway-intact animals [23] .
In the present work, the ventilatory response to hypoxia was unaffected by almitrine treatment. This agrees with the finding that almitrine has no effect on the ventilatory response to hypoxia in anaesthetized rats [24] , and is also consistent with the finding that there is no difference in the carotid chemosensory response to hypoxia after almitrine administration in anaesthetized cats [25] . On the other hand, several studies have reported increases in hypoxic sensitivity after almitrine administration in the cat sensitivity of the chemoreceptors to CO, with almitrine. It is possible that almitrine excited peripheral chemoreceptor activity to the extent that the hypoxic stimulus was not capable of exerting its full effects. It cannot, however, be attributed to the mechanical limits of the ventilatory system, since hypercapnia caused further increases in ventilation. Since hypercapnia acts predominantly on central mechanisms and since hypoxia acts like almitrine via the peripheral chemoreceptors, the hypoxic stimulus may have been masked by almitrine.
The effects of almitrine on the ventilatory response to hypercapnia are controversial. Some investigators have reported increases in hypercapnic sensitivity after almitrine in anaesthetized animals and after (filled ban, n=9) almitrine. * and t indicate significant difference from air and from before almitrine respectively (two-way analysis of variance).
[26] and man [29] . Others, however, have observed no change in the ventilatory response to hypercapnia after almitrine treatment [7] . In the present experiments, the ventilatory responses to 6 and 9% COz were increased after almitrine treatment. Almitrine, by virtue of its specific effects, has been shown to be hypoxic-mimetic [9, 261. In light of this, an increased ventilatory response to hypercapnia after almitrine might be expected, since a combined hypoxic-hypercapnic stimulus is more potent than a hypercapnic stimulus alone. Thus, the present results indicate that in the conscious, unrestrained, tracheostomized rat, almitrine administration has no effect on the hypoxic ventilatory response but enhances the ventilatory response to hypercapnia. In SLN-sectioned animals, almitrine caused a significant increase in respiratory frequency (due to decreases in inspiratory and expiratory duration), minute ventilation and mean inspiratory flow, while breathing air. This pattern of change closely resembled that of SLN-intact animals. However, the tidal component of the ventilatory response to almitrine The calibre of the upper airway is largely dependent on the balance between the stabilizing and dilating force of the upper airway dilator muscles and the collapsing force produced by the inspiratory pump muscles [13] . Conditions such as obstructive apnoea would be favoured by an imbalance between diaphragm and upper airway dilator muscle activity. Few studies, however, have investigated the effects of almitrine on the upper airway musculature. In agreement with the present study, a dose-dependent increase in phrenic and hypoglossal nerve activity has been reported in response to almitrine in anaesthetized, paralysed, vagotomized cats [35] . In that study, however, the magnitude of the response was similar for both nerves. In contrast, almitrine was shown to have no effect on phasic inspiratory genioglossal activity in sleeping cats [36] .
A drug that would preferentially increase the inspiratory activity of upper airway muscles compared with the inspiratory pressure-generating muscles could be beneficial in diseases involving pharyngeal airway collapse. It has been shown that in eight patients with the sleep apnoea syndrome given oral almitrine, there was no reduction in the number of apnoeic events per hour of sleep, but a diminution of mean duration of apnoea was observed for obstructive and mixed apnoeas [ 151.
The large preferential increase in geniohyoid (a representative upper airway dilator muscle) compared with diaphragm EMG activity in the present study suggests that almitrine could be effective in the treatment of clinical apnoeas with both central and obstructive components. The increase in geniohyoid activity might be expected to stabilize and dilate the upper airway and reduce airway resistance. It is well known that activation of upper airway muscles precedes that of the diaphragm and that this is also important for maintaining airway stability [37] . However, almitrine did not affect the amount of geniohyoid preactivation.
An important point to consider is that in the present study, animals were anaesthetized, tracheostomized and vagotomized. Each of these factors has profound effects on upper airway muscle activity and thus caution must be exercised in extrapolating this effect of almitrine to the sleeping, airway-and vagus-intact state. Anaesthesia is known to depress upper airway muscle activity more than diaphragm activity [ 131. As pointed out earlier, Weese-Mayer et al. [36] saw no effect of almitrine on genioglossal activity in sleeping cats with their upper airway and vagi intact. However, in the same experiments, it was demonstrated that vagotomy unmasks an excitatory effect of almitrine on genioglossus EMG activity in anaesthetized cats [36] . The authors concluded that it was the elimination of the inhibition by pulmonary stretch receptors on genioglossus activity due to vagotomy rather than the effects of anaesthesia which evoked the response. In preliminary experiments in the present work, we observed that almitrine also excited geniohyoid muscle activity in anaesthetized, vagus-intact animals. However, since the volume-related increase in vagal afferent activity is markedly reduced during the apnoea caused by airway occlusion, almitrine may have a greater role in restoring upper airway patency during airway occlusion.
In conclusion, the present results demonstrate that the ventilatory response to almitrine is partly mediated by SLN afferents and that almitrine preferentially excites upper airway compared with diaphragm muscle activity. 
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